Concentration Details

Metabolite
HMDB0094677 (Dodecanoic acid, trimethylsilyl ester)
Biospecimen
Feces
Status
Detected but not Quantified
Data source
Referenced
Concentration
Not Quantified
Age
Adult (>18 years old)
Sex
Both
Condition
irritable bowel syndrome
References
    1. Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J: Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26. [PubMed:27662586 ]